What is Avalo Therapeutics's inventories?

Avalo Therapeutics (AVTX) reported inventories of $0 in Q4 2024.

What is the long-term trend for Avalo Therapeutics's inventories?

Over 4 years (2020 to 2024), Avalo Therapeutics's inventories has grown at a -100.0% compound annual growth rate (CAGR), from $3K to $0.

What does inventories mean?

Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

Avalo Therapeutics AVTX Inventories

Discontinued — last reported Q4 '24

Inventories at other companies

Eli LillyLLY

$14.49B+56.1%

AbbVieABBV

$5.05B+11.6%

AbCellera Biologics Inc.ABCL

$7.86M—

Aquestive Therapeutics, Inc.AQST

$8.07M+12.1%

ImmunityBio, Inc.IBRX

$18.86M+123%

Aurinia PharmaceuticalsAUPH

$46.41M+0.5%

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$946.18M+1,783%

Enterprise value$921.19M-1,342%

P/S1,892.4×+1,852×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Avalo Therapeutics’s 10-K, filed March 20, 2025, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's inventories?: Avalo Therapeutics (AVTX) reported inventories of $0 in Q4 2024.
What is the long-term trend for Avalo Therapeutics's inventories?: Over 4 years (2020 to 2024), Avalo Therapeutics's inventories has grown at a -100.0% compound annual growth rate (CAGR), from $3K to $0.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.